Trademark Overview
On Wednesday, April 22, 2026, a trademark application was filed for XL-MAB with the United States Patent and Trademark Office. The USPTO has given the XL-MAB trademark a serial number of 99779946. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 22, 2026. This trademark is owned by XL-protein GmbH. The XL-MAB trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders, ophthalmological diseases, infectious diseases, obesity, diabetes, bone diseases, diseases of the central nervous system, and diseases which can be treated or ameliorated by binding to, or activation or blocking of, a target antigen; proteins, recombinant binding proteins and conjugates of recombinant binding proteins including protein-drug conjugates; pharmaceutical and veterinary preparations comprising proteins, recombinant binding proteins and conjugates of recombinant binding proteins
Scientific services and research relating thereto in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, proteins, and/or medical and veterinary preparations, diagnostic preparations and biomarker reagents and/or diagnostic apparatus
Chemical, biochemical, biological, and biotechnological preparations, in particular, proteins, recombinant binding proteins and conjugates of recombinant binding proteins for industrial and scientific use; proteins, in particular recombinant binding proteins and conjugates of recombinant binding proteins for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, proteins, in particular recombinant binding proteins and conjugates of recombinant binding proteins for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use